Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases

NCT03606499 · clinicaltrials.gov ↗

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease
Colitis, Ulcerative

Interventions

DRUG: Ustekinumab

Sponsor

Janssen Cilag S.A.S.